DK363389A - Anvendelse af imexon som immunsuppressivt middel samt laegemiddel indeholdende imexon - Google Patents

Anvendelse af imexon som immunsuppressivt middel samt laegemiddel indeholdende imexon Download PDF

Info

Publication number
DK363389A
DK363389A DK363389A DK363389A DK363389A DK 363389 A DK363389 A DK 363389A DK 363389 A DK363389 A DK 363389A DK 363389 A DK363389 A DK 363389A DK 363389 A DK363389 A DK 363389A
Authority
DK
Denmark
Prior art keywords
imexon
agent
expressive
immuno
medicinal container
Prior art date
Application number
DK363389A
Other languages
English (en)
Other versions
DK175199B1 (da
DK363389D0 (da
Inventor
Dieter Herrmann
Rainer Haag
Elmar Bosies
Uwe Bicker
Wolfgang Kampe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK363389D0 publication Critical patent/DK363389D0/da
Publication of DK363389A publication Critical patent/DK363389A/da
Application granted granted Critical
Publication of DK175199B1 publication Critical patent/DK175199B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Prostheses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
DK198903633A 1988-07-28 1989-07-21 Anvendelse af imexon som immunsuppressivt middel DK175199B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3825667A DE3825667A1 (de) 1988-07-28 1988-07-28 Verwendung von imexon als immunsuppressivum
DE3825667 1988-07-28

Publications (3)

Publication Number Publication Date
DK363389D0 DK363389D0 (da) 1989-07-21
DK363389A true DK363389A (da) 1990-01-29
DK175199B1 DK175199B1 (da) 2004-07-05

Family

ID=6359767

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198903633A DK175199B1 (da) 1988-07-28 1989-07-21 Anvendelse af imexon som immunsuppressivt middel

Country Status (14)

Country Link
EP (1) EP0352652B1 (da)
JP (1) JP2848634B2 (da)
KR (1) KR0135757B1 (da)
AT (1) ATE117551T1 (da)
AU (1) AU619027B2 (da)
CA (1) CA1333771C (da)
DE (2) DE3825667A1 (da)
DK (1) DK175199B1 (da)
HU (1) HU206827B (da)
IE (1) IE66680B1 (da)
IL (1) IL91138A (da)
PH (1) PH26684A (da)
PT (1) PT91293B (da)
ZA (1) ZA895710B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005055952A2 (en) * 2003-12-08 2005-06-23 The Arizona Board Of Regents On Behalf Of The University Of Arizona Synergistic anti-cancer compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2528460A1 (de) * 1975-06-26 1977-01-13 Boehringer Mannheim Gmbh Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans
DE2530398A1 (de) * 1975-07-08 1977-01-27 Boehringer Mannheim Gmbh Organische verbindung
DE2736296A1 (de) * 1977-08-12 1979-02-22 Boehringer Mannheim Gmbh Verwendung von 2-cyan-aziridin und seinen derivaten zur immunstimulierung

Also Published As

Publication number Publication date
JPH0288521A (ja) 1990-03-28
HU206827B (en) 1993-01-28
IE892448L (en) 1990-01-28
PH26684A (en) 1992-09-15
ZA895710B (en) 1990-04-25
EP0352652A2 (de) 1990-01-31
DK175199B1 (da) 2004-07-05
IE66680B1 (en) 1996-01-24
PT91293B (pt) 1995-03-01
PT91293A (pt) 1990-02-08
CA1333771C (en) 1995-01-03
EP0352652B1 (de) 1995-01-25
HUT52378A (en) 1990-07-28
ATE117551T1 (de) 1995-02-15
DE58908926D1 (de) 1995-03-09
EP0352652A3 (de) 1991-09-04
KR900001369A (ko) 1990-02-27
JP2848634B2 (ja) 1999-01-20
AU619027B2 (en) 1992-01-16
DE3825667A1 (de) 1990-03-15
IL91138A0 (en) 1990-03-19
KR0135757B1 (ko) 1998-04-23
AU3887789A (en) 1990-02-01
IL91138A (en) 1994-10-21
DE3825667C2 (da) 1991-06-27
DK363389D0 (da) 1989-07-21

Similar Documents

Publication Publication Date Title
ES2125233T3 (es) Tratamiento de las infecciones retrovirales humanas con 2',3'-didesoxiinosina.
NO903925D0 (no) Fremgangsmaate for fremstilling av 3-(1-substituert-4-piperazinyl)-1h-indazoler samt anvendelse som legemidler.
ES2058725T3 (es) Aplicacion transdermica de 2-amino-6-n-propilamino-4,5,6,7-tetrahidrobenzotiazol.
FR2624720B1 (fr) Implant pour dispositif d'osteosynthese, notamment du rachis
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
ATE77755T1 (de) Kontrastmittel mit stabilen, freien radikalen.
KR950005323A (ko) 면역조정, 항염증제
DK36889D0 (da) Anvendelse af et benzamidderivat til fremstilling af et middel til behandling eller forebyggelse af kognitive lidelser
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
FR2694296B1 (fr) Peptides inhibant l'activité des protéines ras, préparation et utilisation.
NO903527D0 (no) Laboratorieanordning, samt fremgangsmaate for behandling av steinproever.
UA27713C2 (uk) Амідинові похідні бензолу, що мають гіпоглікемічну активність, та їх фармацевтично прийнятні солі
DK0391185T3 (da) 1,8-Naphthyridiner
DK363389A (da) Anvendelse af imexon som immunsuppressivt middel samt laegemiddel indeholdende imexon
FR2600870B1 (fr) Dispositif vaporisateur de parfum.
DE68911974D1 (de) Ophthalmologisches Diagnose-Verfahren und Gerät.
NO902934L (no) Fremgangsmaate for fremstilling av 4h-indolo(1,2-d)(1,2,4)-triazolo(4,3-a)(1,4)benzodiazepiner, samt anvendelse som medikamenter.
ATE107165T1 (de) Verwendung von macrolactonen als antiallergica.
NO901076D0 (no) Substituerte bifenyler.
FI102065B1 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia 2-amino-4-morfolino-6-propyyli-1,3,5-triatsiineja
PT91610A (pt) Process for the preparation of compounds for the treatment of arteritis rheumatoidal
NO893037L (no) Anordning for sjoebunn-understoettelse av plattform-ben, samt plattform med slike anordninger.
KR970000329A (ko) 흡수제
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma
IT8920585A0 (it) Uso di composti triciclici fluorochinolonici nel trattamento dell'artrite reumatoide.

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK